Stay updated on Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Footer now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates the page has been updated to a newer version without altering study details or functionality.
    Difference
    0.1%
    Check dated 2026-07-04T08:30:18.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.0 to v3.6.2. This indicates a minor site version bump; no substantive content changes in the study details.
    Difference
    0.1%
    Check dated 2026-06-27T04:13:52.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment note states No longer looking for participants. The Intervention/Treatment heading formatting was adjusted and the revision updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T23:44:58.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5, indicating a minor behind-the-scenes update to the page template or system release.
    Difference
    0.1%
    Check dated 2026-06-05T22:04:54.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a deployment update to the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-05-15T15:19:09.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page revision label was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T06:18:30.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.